Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Astrug

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Methods and Findings in Experimental and Clinical Pharmacology|September 1, 1989
Effects of some beta-adrenoceptor blockers on avoidance learning in ratsD Staneva-Stoytcheva, A Astrug, D Ivanov
Vutreshni Bolesti|January 1, 1977
[Immunological studies in diabetic nephropathy]A Astrug, G Kosturkov, N Belovezhdov, et al.
Vutreshni Bolesti|January 1, 1974
[A study of renal function using radioisotope methods in patients with diabetic nephropathy]A Astrug, E Sheĭretova, S Ketskarova, et al.
Vutreshni Bolesti|January 1, 1975
[131-I-hippuran clearance and isotopic nephrography in patients with endemic nephropath]E Sheĭretova, A Astrug, S Ketskarova, et al.
Vutreshni Bolesti|January 1, 1972
[Serum glutamyl transpeptidase in patients with endemic nephritis]D Adzharov, E Ivanov, A Astrug, et al.
Vutreshni Bolesti|January 1, 1974
[I-131-hippuran clearance and isotope nephrography in chronic pyelonephritis]E Sheĭretova, A Astrug, S Ketskarova, et al.
Akusherstvo I Ginekologiia|February 5, 2008
[Drugs in pregnancy]N Danchev, A Astrug, V Tsankova, et al.
Vutreshni Bolesti|January 1, 1980
[Diagnostic significance of lysozymuria in chronic pyelonephritis]L Todorova, A Astrug, S Danev, et al.
Eksperimentalna Meditsina I Morfologiia|January 1, 1979
[Pharmacokinetics of the pressor substance, 5,8-dimethoxy-trans-2-(2-hydroxyethyl)-amino-3-hydroxy-1,2,3,4-tetrahydronaphthalene hydrochloride (1b), after intravenous use]D Mikhaĭlova, A Astrug, D Staneva, et al.
Vutreshni Bolesti|January 1, 1974
[Hereditary nephritis with bearing loss of the receiver type (Alport's syndrome) with a description of 2 cases]N Zhelev, A Astrug, B Konstantinova, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Methods and Findings in Experimental and Clinical Pharmacology|September 1, 1989
Effects of some beta-adrenoceptor blockers on avoidance learning in ratsD Staneva-Stoytcheva, A Astrug, D Ivanov
Vutreshni Bolesti|January 1, 1977
[Immunological studies in diabetic nephropathy]A Astrug, G Kosturkov, N Belovezhdov, et al.
Vutreshni Bolesti|January 1, 1974
[A study of renal function using radioisotope methods in patients with diabetic nephropathy]A Astrug, E Sheĭretova, S Ketskarova, et al.
Vutreshni Bolesti|January 1, 1975
[131-I-hippuran clearance and isotopic nephrography in patients with endemic nephropath]E Sheĭretova, A Astrug, S Ketskarova, et al.
Vutreshni Bolesti|January 1, 1972
[Serum glutamyl transpeptidase in patients with endemic nephritis]D Adzharov, E Ivanov, A Astrug, et al.
Vutreshni Bolesti|January 1, 1974
[I-131-hippuran clearance and isotope nephrography in chronic pyelonephritis]E Sheĭretova, A Astrug, S Ketskarova, et al.
Akusherstvo I Ginekologiia|February 5, 2008
[Drugs in pregnancy]N Danchev, A Astrug, V Tsankova, et al.
Vutreshni Bolesti|January 1, 1980
[Diagnostic significance of lysozymuria in chronic pyelonephritis]L Todorova, A Astrug, S Danev, et al.
Eksperimentalna Meditsina I Morfologiia|January 1, 1979
[Pharmacokinetics of the pressor substance, 5,8-dimethoxy-trans-2-(2-hydroxyethyl)-amino-3-hydroxy-1,2,3,4-tetrahydronaphthalene hydrochloride (1b), after intravenous use]D Mikhaĭlova, A Astrug, D Staneva, et al.
Vutreshni Bolesti|January 1, 1974
[Hereditary nephritis with bearing loss of the receiver type (Alport's syndrome) with a description of 2 cases]N Zhelev, A Astrug, B Konstantinova, et al.
Pageof 3